(1)
Mehić, B.; Stanetić, M.; Tinjić, L.; Smoljanović, V. Our Experiences With Erlotinib in Second and Third Line Treatment Patients With Advanced Stage Iiib/ Iv Non-Small Cell Lung Cancer. Bosn J of Basic Med Sci 2008, 8, 386-390.